RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Thiazolidinedione use is associated with reduced risk of Parkinson's disease in patients with diabetes: a meta-analysis of real-world evidence.

Thiazolidinedione use is associated with reduced risk of Parkinson's disease in patients with diabetes: a meta-analysis of real-world evidence.

Add to Collection
2020 Dec Systematic Review and Meta Analysis S Hussain, A Singh, H Baxi, B Taylor, J Burgess… - Neurological …, 2020 - Springer

Full Author : ['Hussain, Salman', 'Singh, Ambrish', 'Baxi, Harveen', 'Taylor, Bruce', 'Burgess, John', 'Antony, Benny']
Journal Title : Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Chapter : Section17, Section2, Section4
Journal Year : 2020
Cited by : 17

BACKGROUND: The thiazolidinedione (TZD) class of oral antidiabetic agents are used to treat type 2 diabetes mellitus (DM). This meta-analysis aimed to understand the protective effect of TZD on Parkinson's disease (PD) in people with diabetes. METHOD: A l..... Read More

Keywords : ['thiazolidinedione use', 'reduce risk', 'realworld evidence', 'parkinson disease', 'patient', 'metaanalysis', 'diabete', 'associate']
PubMed Link : https://link.springer.com/article/10.1007/s10072-020-04494-3
Google Scholar Link : https://scholar.google.com/scholar?cites=9421988740966164038&as_sdt=5,33&sciodt=0,33&hl=en&num=20